Jorge Hechavarria is the Senior Director, Diversity, Equity & Inclusion in Clinical Trials (DEICT), part of the Patient & Portfolio Solutions (PPS), in Janssen. In this role, his primary responsibilities are to develop, deliver and continuously evolve the future vision for DEICT at Janssen and will lead a team that co-develops and delivers diversity and inclusion strategies related to DEICT across all Therapeutic Areas and regions. Jorge serves as an advisor to Therapeutic Area and Global Development leaders to partner to continuously design and scale DEICT capabilities to enable better clinical trial design, operational optimization across all Janssen clinical trials. In this role, Jorge will lead & support select business transformation projects in support of high-visibility global strategic initiatives in PMO Portfolio Management and other areas and has a team of highly talented individuals supporting various therapeutic areas.
Jorge most recently was from Celgene/Bristol Myers Squibb where he served as Head, US REMS Global Risk Management Quality Operations. He has significant executive experience in stakeholder management, vendor, CRO, contract and project management over the past 25 years. Across various roles in the industry, he has consistently driven diversity and inclusion efforts across business units. Jorge has also authored several publications, has been an active speaker at industry conferences and serves on various healthcare related councils and advisory boards.
Jorge received his Bachelor of Science in Organizational Management from NYACK College, his Masters of Business Administration from University of Phoenix and his PhD in Health and Medical Sciences Leadership from Seton Hall University. He resides in New Jersey with his wife and two daughters.